Vaxart Files 8-K/A Amendment
Ticker: VXRT · Form: 8-K/A · Filed: Jun 20, 2024 · CIK: 72444
| Field | Detail |
|---|---|
| Company | Vaxart, Inc. (VXRT) |
| Form Type | 8-K/A |
| Filed Date | Jun 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-governance, filing-update
Related Tickers: VXRT
TL;DR
Vaxart filed an amendment to an earlier 8-K, likely a correction or update on a shareholder vote.
AI Summary
Vaxart, Inc. filed an amendment (8-K/A) on June 20, 2024, to its previous filing concerning a matter submitted to a vote of security holders on June 11, 2024. The amendment does not provide new substantive details about the vote itself but serves to correct or supplement information previously disclosed.
Why It Matters
This filing indicates a procedural update or correction to a previous disclosure regarding a shareholder vote, suggesting ongoing corporate governance activities.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, typically for corrections or minor updates, and does not introduce new material risks.
Key Players & Entities
- Vaxart, Inc. (company) — Registrant
- June 11, 2024 (date) — Date of earliest event reported
- June 20, 2024 (date) — Date of report (filing date of amendment)
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing serves as an amendment to a previously filed 8-K, indicating a correction or supplement to information previously reported regarding a matter submitted to a vote of security holders.
What was the original date of the event reported?
The earliest event reported in the original filing was on June 11, 2024.
What is the filing date of this amendment?
This amendment (8-K/A) was filed on June 20, 2024.
What is the company's exact name and state of incorporation?
The company's exact name is Vaxart, Inc., and it is incorporated in Delaware.
Does this amendment introduce new substantive information about the shareholder vote?
Based on the provided text, this filing is an amendment and does not appear to introduce new substantive details about the shareholder vote itself, but rather corrects or supplements prior information.
Filing Stats: 619 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-06-20 16:06:40
Key Financial Figures
- $0.0001 — nge on which registered Common Stock , $0.0001 par value VXRT The Nasdaq Capital M
Filing Documents
- vxrt20240619_8ka.htm (8-K/A) — 29KB
- 0001437749-24-020779.txt ( ) — 162KB
- vxrt-20240611.xsd (EX-101.SCH) — 3KB
- vxrt-20240611_def.xml (EX-101.DEF) — 12KB
- vxrt-20240611_lab.xml (EX-101.LAB) — 15KB
- vxrt-20240611_pre.xml (EX-101.PRE) — 12KB
- vxrt20240619_8ka_htm.xml (XML) — 3KB
07
Item 5.07 Submission of Matters to a Vote of Security Holders. In the Original Report, the Company disclosed the voting results for the proposals submitted to a stockholder vote at the Annual Meeting. The Company subsequently learned of a calculation error in the results reported to the Company for Proposal No. 2 (regarding the adoption of an amendment to the Company's Restated Certificate of Incorporation to increase the Company's authorized number of shares of common stock from 250,000,000 shares to 350,000,000 shares) and the Company's outside voting tabulation firm provided corrected voting results for Proposal No. 2. Although the corrected voting results do not change the outcome for Proposal No. 2, the Company is filing this amendment to the Original Report to provide the corrected information received from its outside voting tabulation firm. Proposal 2 . Stockholders approved the adoption of an amendment to the Company's Restated Certificate of Incorporation to increase the Company's authorized number of shares of common stock from 250,000,000 shares to 350,000,000 shares. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 35,936,013 21,134,398 491,543 47,701,989
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VAXART, INC. Dated: June 20, 2024 By: /s/ Steven Lo Steven Lo President and Chief Executive Officer